Insights & News

Start Date

End Date

Get Our Updates

View:

Blog

From Credibility to Admissibility: Reblending the Expert Playbook Under Rule 702

December 9, 2025

Blog

Delaware Supreme Court Reverses Trial Court Decision on Zantac Expert Testimony

July 16, 2025

Blog

FDCA Preemption Has Teeth for Benzene Failure-to-Warn Claims

June 24, 2025

Speaking Engagement

Rand Brothers Discusses Microplastics: Regulation, Litigation, and Emerging Trends

April 1, 2025

Blog

You Are What You Say You Are: Ruling Emphasizes Product Representations Mean What They “Actually Say”

March 26, 2025

Blog

The Fall of a Faulty Expert: Lessons from Monte v. Sherwin-Williams

March 5, 2025

Blog

Water Bottle Manufacturer Springs Ahead in Microplastics Challenge

December 11, 2024

Press Release

Winston & Strawn Names 20 New Partners

December 3, 2024

Blog

Third-Party Litigation Financing Under the Spotlight: Judicial Conference Subcommittee Formed to Explore Disclosure Rules

October 28, 2024

Blog

Faulty Triggers or Faulty Testimony? Court Rejects Unreliable Experts in Design Defect Case

October 25, 2024

Recognitions

Winston & Strawn Recognized in The Legal 500 U.S. 2024

June 12, 2024

Blog

A Potential Shield: FDCA Preemption in Product Liability and Mass Torts Litigation

May 6, 2024

Article

Tylenol MDL Highlights Expert Admissibility Headaches

May 3, 2024

Blog

In re Acetaminophen MDL Court Highlights the Significance of Regulator and Medical Organization Conclusions on Causation in Assessing Expert Methodologies

February 23, 2024

Blog

In re Acetaminophen MDL Reiterates That Cherry-Picking Data And Exceeding Study Limitations Are Unreliable Expert Methodologies

February 2, 2024

Blog

Are “Shared” Bradford Hill Analyses an Admissible Expert Causation Methodology? In re Acetaminophen MDL Court Says No

January 12, 2024

Blog

New Jersey Appellate Court Reverses Plaintiff Jury Verdict in Talc Litigation Based on Improperly Admitted Plaintiff Expert Opinions

December 5, 2023

Blog

Beyond the Obvious: Does the Failure to Rule Out Idiopathic Causes Survive a Rule 702 Challenge?

November 17, 2023

Copyright © 2026. Winston & Strawn LLP

Alumni Corporate Transparency Act Task Force DEI Compliance Task Force Equal Rights Amendment Law Glossary The Oval Update Winston Minute Privacy Policy Cookie Policy Fraud & Scam Alerts Notices SubscribeAttorney Advertising